PCNL in neurogenic bladder: A challenging population for both clinical management and analysis.

2023-11

Heijkoop, Bridget

Chislett, Bodie

Perera, Marlon

Esler, Stephen J

Bolton, Damien M

Webb, David Rowan

PCNL

neurogenic bladder

percutaneous nephrolithotomy

renal stones

spinal cord injury

Journal Article

0000-0001-6348-5445

#PLACEHOLDER_PARENT_METADATA_VALUE#

0000-0002-1138-6389

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

10.1002/bco2.268

To review the management of patients with neurogenic bladder undergoing percutaneous nephrolithotomy (PCNL) at our institution with the aim of assessing peri-operative morbidity. We conducted a retrospective review of all neurogenic bladder patients who underwent PCNL at our hospital in the last decade with the aim of assessing peri-operative morbidity. A total of 298 PCNL were performed during the study period of which 58 were in patients with a neurogenic bladder or urinary diversion, 33 of which were in SCI patients. Preoperative demographic and stone characteristics, intraoperative data and postoperative length of stay and complications are summarised in table form. PCNL remains an acceptably safe and efficacious treatment for upper tract stone disease in patients with neurogenic bladders and will continue to have a valuable role where SCI prevents alternative approaches such as ureteroscopy.

link

BJUI Compass 2023-11; 4(6)

BJUI Compass

2688-4526